Loading...
Docoh

Aptinyx (APTX)

295 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2022 Q1
APTX Aptinyx Inc
12 May 22
Quarterly report
4:30pm
8-K
APTX Aptinyx Inc
12 May 22
Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress
4:16pm
8-K
APTX Aptinyx Inc
19 Apr 22
Other Events
7:00am
DEFA14A
APTX Aptinyx Inc
13 Apr 22
Additional proxy soliciting materials
8:24pm
DEF 14A
APTX Aptinyx Inc
13 Apr 22
Definitive proxy
7:51pm
8-K
APTX Aptinyx Inc
7 Apr 22
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
7:15am
EFFECT
APTX Aptinyx Inc
1 Apr 22
Notice of effectiveness
12:15am
424B5
APTX Aptinyx Inc
31 Mar 22
Prospectus supplement for primary offering
4:45pm
CORRESP
APTX Aptinyx Inc
28 Mar 22
Correspondence with SEC
8:00pm
UPLOAD
APTX Aptinyx Inc
27 Mar 22
Letter from SEC
8:00pm
S-3
APTX Aptinyx Inc
24 Mar 22
Shelf registration
9:34am
S-8
APTX Aptinyx Inc
23 Mar 22
Registration of securities for employees
4:21pm
10-K
2021 FY
APTX Aptinyx Inc
23 Mar 22
Annual report
4:15pm
8-K
APTX Aptinyx Inc
23 Mar 22
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights
4:05pm
8-K
APTX Aptinyx Inc
28 Feb 22
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
8:15am
4
Ashish Khanna
22 Feb 22
Aptinyx / ASHISH KHANNA ownership change
4:30pm
SC 13D/A
APTX Aptinyx Inc
10 Feb 22
Aptinyx / New Leaf Ventures III ownership change
7:00pm
8-K
APTX Aptinyx Inc
8 Feb 22
Regulation FD Disclosure
7:00pm
4
Joan W. Miller
18 Jan 22
Aptinyx / Joan W. Miller ownership change
4:19pm
8-K
APTX Aptinyx Inc
3 Jan 22
Departure of Directors or Certain Officers
7:30am